Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

2(40.0%)

5Total

N/A(3)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02357654Phase 4Recruiting

GnRH for Luteal Support in IVF/ICSI/FET Cycles

Role: lead

NCT00889512Phase 4Terminated

The Luveris In Vitro Fertilization Trial

Role: lead

NCT02621125Not ApplicableWithdrawn

Fertilix Supplements and Assisted Reproductive Technology

Role: lead

NCT00839839Not ApplicableCompleted

Egg Freezing Pilot Study

Role: lead

NCT01237106Not ApplicableCompleted

In Vitro Maturation (IVM) for Polycystic Ovary Syndrome (PCOS)

Role: lead

NCT01002885Completed

Follicle Stimulating Hormone (FSH) Receptor Polymorphisms in In-Vitro Fertilization Cycles.

Role: lead

All 6 trials loaded